Experiment 352882

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

INGENOL-3-5-20-TRIACETATE

Details

PropertyValue
Pharmacology
RECEPTOR REGULATING EFFECT(UNSPECIFIED)
OrganismEmpty organism
CitationFUJIWARA,MT: IJICHI,KS: TOKUHISA,KJ: KATSUURA,KM: SHIGETA,SR: KONNO,KJ: WANG,GYS: UEMURA,DS: YOKOTA,TY: BABA,MN:. (1996). MECHANISM OF SELECTIVE INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS BY INGENOL TRIACETATE.. 40(1)
Amount utilized
Compound isolated
DiseaseVS.CD26 EXPRESSION.
Dose amount50.0 MICROMOLS
Number14
Qualitative resultINACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED